More
    Guided Solutions - Connecting Talent With Innovation/div>

    TAE Life Sciences and Stella Pharma announce strategic agreement for development and commercialisation of BPA for BNCT Cancer Therapy

    TAE Life Sciences (TLS), a leader in developing boron neutron capture therapy (BNCT) technology and associated innovative boron target drugs, and Stella Pharma, the...

    OrganOx and eGenesis announce exclusive clinical co-development agreement for treatment of patients with liver failure in the acute setting

    OrganOx, a medical technology company developing innovative solutions for organ preservation and eGenesis, a biotechnology company developing human-compatible organs for patients with organ failure,...

    Biomendex enters collaboration with Mayo Clinic

    Biomendex is continuing the development of its fully synthetic and biodegradable bone graft material, Adaptos, to enable better outcomes for patients and surgeons. Currently, Biomendex...

    Latest articles